QOL Medical to Acquire All Outstanding Shares of Evoke for $11.00 Per Share in CashRepresents a 139.7% premium to most recent ...

Evoke Pharma surges after QOL Medical announces $11 cash acquisition, a 140% premium, expected to close by the end of 2025.

Evoke Pharma (EVOK) jumped over 130% in premarket trading on Tuesday after announcing that the company would be acquired by ...

QOL agreed to buy Evoke for $11 a share in a deal expected to close by the end of the year. QOL said it will fund the transaction with cash on hand. Shares of Evoke have more than doubled to $10.70 ...

Evoke Pharma (NASDAQ:EVOK) shares surged 134% on Tuesday after the company revealed it had signed a definitive agreement to be acquired by QOL Medical, a privately held biopharmaceutical company ...

Rick Buoncore remains chairman and CEO of the now $65 billion RIA, with former Evoke co-founder and head David Hou taking the ...

Investing.com -- Evoke Pharma (NASDAQ:EVOK) stock surged 134% following the announcement that the company has entered into a definitive agreement to be acquired by QOL Medical, a privately held ...

Wall Street says tokenization will change global markets. Gold is next.